ddwn and dplane , I am thinking about the video we watched the other day, the panel discussion on rogue stem cell practitioners in the USA...and I am wondering if this could possibly contribute to why the fda are requesting further scientific rationale? Perhaps they want tighter definitions or parameters to protect patients and practitioners. Perhaps they want tighter definitions in order to prosecute rogue practitioners who may seek to provide a similar service. Competition. Regulation.
Just a thought...
MSB Trading 2020 - a new dawn, page-8275
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.118(9.44%) |
Mkt cap ! $1.512B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $15.74M | 11.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1877 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.37 | 51281 | 16 |
View Market Depth
| Last trade - 15.45pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |